All In Biotech

Drug Trial Radar · NCT00501982

Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study

An International, Open, Randomized, Controlled Study to Evaluate the Efficacy of Combining Prophylactic Curosurf® With Early Nasal CPAP Versus Early Nasal CPAP Alone in Very Preterm Infants at Risk of Respiratory Distress Syndrome

Last checked: Nov 20, 2026Latest source record: Aug 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 208 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

208

Actual

Start

Mar 2007

Primary completion

May 2008

Study completion May 2008

Sponsor

Lead sponsor
Chiesi Farmaceutici S.p.A.Industry
Sponsor type
Industry
First posted
Jul 17, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 25 weeks, up to 28 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to compare two methods of post-delivery stabilization and subsequent early respiratory care for reducing the need for MV and related secondary complications, such as BPD, in premature babies at high risk of RDS: 1. Early stabilization on nCPAP 2. Intubation, prophylactic surfactant (Curosurf®) administration shortly after delivery, and rapid extubation to nCPAP. The data obtained from this comparison will be applied to test the hypothesis that preterm neonates at risk of RDS who are treated with prophylactic surfactant + nCPAP show less need for MV when compared to infants who receive nCPAP alone.

Conditions

  • Respiratory Distress Syndrome, Newborn

Interventions

  • Poractant alfa (Curosurf®)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Need for MVTime frame: Within the first 5 days of life

Locations

5 sites in 5 countries. Site status is shown where the registry gives one.

  • General Faculty Hospital

    Prague, Czechia

  • Hopital De La Conception

    Marseille, France

  • Ospedale Maggiore

    Bologna, Italy

  • Maternidade Alfredo da Costa

    Lisbon, Portugal

  • Hospital De Cruces

    Bilbao, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.